(S)-N-BOC-2-Naphthylalanine

(S)-N-BOC-2-Naphthylalanine - Names and Identifiers

Name	(S)-N-BOC-2-Naphthylalanine
Synonyms	Boc-2-Nal-OH BOC-2-NAL-OH BOC-ALA(2-NAPH)-OH Boc-Ala(2-Naphthyl)-OH BOC-ALA(2-NAPHTHYL)-OH BOC-2-L-NAPHTHYLALANINE Boc-L-2-Naphthylalanine BOC-(2-naphthyl)alanine BOC-3-(2-NAPHTHYL)-ALANINE (S)-N-BOC-2-Naphthylalanine Boc-L-3-(2-Naphthyl)alanine Boc-3-(2-Naphthyl)-L-alanine BOC-ALA-BETA-(2-NAPHTHYL)-OH N-tert-Butoxycarbonyl-2-naphthyl-L-alanine NALPHA-tert-Butoxycarbonyl-3-(2-naphthyl)-L-alanine N-(tert-butoxycarbonyl)-3-naphthalen-2-yl-L-alanine N-(tert-butoxycarbonyl)-3-naphthalen-2-yl-D-alanine (2S)-2-[(tert-butoxycarbonyl)amino]-3-naphthalen-2-ylpropanoate
CAS	58438-04-3
InChI	InChI=1/C18H21NO4/c1-18(2,3)23-17(22)19-15(16(20)21)11-12-8-9-13-6-4-5-7-14(13)10-12/h4-10,15H,11H2,1-3H3,(H,19,22)(H,20,21)/t15-/m0/s1

(S)-N-BOC-2-Naphthylalanine - Physico-chemical Properties

Molecular Formula	C18H21NO4
Molar Mass	315.36
Density	1.2164 (rough estimate)
Melting Point	92-95°C(lit.)
Boling Point	454.92°C (rough estimate)
Flash Point	263.6°C
Vapor Presure	2.58E-11mmHg at 25°C
Appearance	Solid
Color	Off-white
BRN	4326467
pKa	3.88±0.30(Predicted)
Storage Condition	Sealed in dry,Room Temperature
Refractive Index	1.5740 (estimate)
MDL	MFCD00079671

(S)-N-BOC-2-Naphthylalanine - Risk and Safety

Hazard Symbols	Xi - Irritant
Safety Description	S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes.
WGK Germany	3
HS Code	29225090
Hazard Class	IRRITANT

(S)-N-BOC-2-Naphthylalanine - Reference Information

Use

Boc-3-(2-naphthyl)-L-alanine is an amino acid derivative, which can be 3-(2-naphthyl)-L-alanine is protected by Boc anhydride. It is reported that Boc-3-(2-naphthyl)-L-alanine can be used to prepare lanreotide (Lanreotide). Lanreotide is a somatostatin octapeptide analog, which is more active than natural somatostatin and has similar properties to octreotide. Long-acting injection is used to treat acromegaly and thyroid-stimulating hormone adenoma, and can also be used to control the symptoms of neuroendocrine tumors, especially carcinoid syndrome.

Last Update：2024-04-09 02:00:01